Dr Reguart speaks with ecancer at ESMO 2018 in Munich about highlights from the ESMO session she moderated on small cell lung cancer. She highlights work with new targeted therapies, including checkpoint combinations, antibodantibody-drugates and...
Original Article: Highlights in SCLC from ESMO 2018